Male Hypogonadism Market Size, Share, Trends, Growth and Forecast 2032
Male Hypogonadism Market- by Therapy (Testosterone replacement therapy, Gonadotropin-releasing hormones therapy), by Drug delivery (Injectables, Topical gels, Transdermal patches, Others), by Type (Kallmann syndrome, Klinefelters syndrome, Pituitary disorders, Others) - Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.63 Billion | USD 5.83 Billion | 5.4% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Pituitary disorders Scope
- 1.3. Pituitary disorders Methodology
- 1.3.1. Market Pituitary disorders Process
- 1.3.2. Market Pituitary disorders Methodology
- Chapter 2. Executive Summary
- 2.1. Male Hypogonadism Market, 2016 - 2026, (USD Million)
- 2.2. Male Hypogonadism Market: Snapshot
- Chapter 3. Global Male Hypogonadism Market – Industry Analysis
- 3.1. Male Hypogonadism Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing case of testosterone deficiency among men.
- 3.2.2. Rising infertility rates accompanied with rising awareness among individuals regarding hypogonadism treatment
- 3.3. Restraints
- 3.3.1. High side effects
- 3.4. Opportunity
- 3.4.1. Increase in research and development in pharmaceutical sector
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Therapy segment
- 3.6.2. Market attractiveness analysis by Drug delivery segment
- 3.6.3. Market attractiveness analysis by Type segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global Male Hypogonadism Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Male Hypogonadism market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Disease category launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Pituitary disorders and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Male Hypogonadism Market – Therapy Segment Analysis
- 5.1. Global Male Hypogonadism market overview: by Therapy
- 5.1.1. Global Male Hypogonadism market revenue share, by Therapy, 2019 and 2026
- 5.2. Testosterone replacement therapy
- 5.2.1. Global Male Hypogonadism market by Testosterone replacement therapy, 2016-2026 (USD Million)
- 5.3. Gonadotropin-releasing hormones therapy
- 5.3.1. Global Male Hypogonadism market by Gonadotropin-releasing hormones therapy, 2016-2026 (USD Million)
- 5.1. Global Male Hypogonadism market overview: by Therapy
- Chapter 6. Global Male Hypogonadism Market – Drug delivery Segment Analysis
- 6.1. Global Male Hypogonadism market overview: by Drug delivery
- 6.1.1. Global Male Hypogonadism market revenue share, by Drug delivery, 2019 and 2026
- 6.2. Injectables
- 6.2.1. Global Male Hypogonadism market by Injectables, 2016-2026 (USD Million)
- 6.3. Topical gels
- 6.3.1. Global Male Hypogonadism market by Topical gels, 2016-2026 (USD Million)
- 6.4. Transdermal patches
- 6.4.1. Global Male Hypogonadism market by Transdermal patches, 2016-2026 (USD Million)
- 6.5. Others
- 6.5.1. Global Male Hypogonadism market by Others, 2016-2026 (USD Million)
- 6.1. Global Male Hypogonadism market overview: by Drug delivery
- Chapter 7. Global Male Hypogonadism Market – Type Segment Analysis
- 7.1. Global Male Hypogonadism market overview: by Type
- 7.1.1. Global Male Hypogonadism market revenue share, by Type, 2019 and 2026
- 7.2. Kallmann syndrome
- 7.2.1. Global Male Hypogonadism market by Kallmann syndrome, 2016-2026 (USD Million)
- 7.3. Klinefelters syndrome
- 7.3.1. Global Male Hypogonadism market by Klinefelters syndrome, 2016-2026 (USD Million)
- 7.4. Pituitary disorders
- 7.4.1. Global Male Hypogonadism market by Pituitary disorders, 2016-2026 (USD Million)
- 7.5. Transplant
- 7.5.1. Global Male Hypogonadism market by Transplant, 2016-2026 (USD Million)
- 7.1. Global Male Hypogonadism market overview: by Type
- Chapter 8. Global Male Hypogonadism Market - Regional Analysis
- 8.1. Global Male Hypogonadism market overview: by region
- 8.1.1. Global Male Hypogonadism market revenue share, by region, 2019 and 2026
- 8.2. North America
- 8.2.1. North America Male Hypogonadism market, by country, 2016-2026 (USD Million)
- 8.2.2. North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.2.3. North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.2.4. North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.2.5.2. The U.S. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.2.5.3. The U.S. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.2.6.2. Rest of North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.2.6.3. Rest of North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Male Hypogonadism market, by country, 2016-2026 (USD Million)
- 8.3.2. Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.3.3. Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.3.4. Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.3.5. U.K.
- 8.3.5.1. U.K. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.3.5.2. U.K. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.3.5.3. U.K. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.3.6.2. France Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.3.6.3. France Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Germany Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.3.7.2. Germany Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.3.7.3. Germany Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.3.8.2. Rest of Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.3.8.3. Rest of Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Male Hypogonadism market, by country, 2016-2026 (USD Million)
- 8.4.2. Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.4.3. Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.4.4. Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.4.5. China
- 8.4.5.1. China Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.4.5.2. China Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.4.5.3. China Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.4.6.2. Japan Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.4.6.3. Japan Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.4.7. India
- 8.4.7.1. India Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.4.7.2. India Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.4.7.3. India Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.4.8.2. Rest of Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.4.8.3. Rest of Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Male Hypogonadism market, by country, 2016-2026 (USD Million)
- 8.5.2. Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.5.3. Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.5.4. Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.5.5.2. Brazil Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.5.5.3. Brazil Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.5.6.2. Rest of Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.5.6.3. Rest of Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa Male Hypogonadism market, 2016-2026 (USD Million)
- 8.6.2. Middle East & Africa Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
- 8.6.3. Middle East & Africa Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
- 8.6.4. Middle East & Africa Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
- 8.1. Global Male Hypogonadism market overview: by region
- Chapter 9. Company Profiles
- 9.1. Astrazeneca Plc
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Merck & Co. Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Laboratories Genevrier
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Allergan Plc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Endo International Plc
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. Ferring.
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. AbbVie Inc
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Eli Lilly and Company Ltd
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Finox Biotech.
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. Teva Pharmaceutical Industries Ltd
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.1. Astrazeneca Plc
Table Of Figures
List of Figures
1. Market Pituitary disorders process
2. Market Pituitary disorders methodology
3. Global Male Hypogonadism market, 2016-2026 (USD Million)
4. Porter’s five forces analysis: Male Hypogonadism market
5. Global Male Hypogonadism market attractiveness, by Therapy
6. Global Male Hypogonadism market attractiveness, by Drug delivery
7. Global Male Hypogonadism market attractiveness, by Type
8. Global Male Hypogonadism market revenue share, by Therapy, 2019 and 2026
9. Global Male Hypogonadism market by Testosterone replacement therapy, 2016-2026 (USD Million)
10. Global Male Hypogonadism market by Gonadotropin-releasing hormones therapy, 2016-2026 (USD Million)
11. Global Male Hypogonadism market revenue share, by Drug delivery, 2019 and 2026
12. Global Male Hypogonadism market by Injectables, 2016-2026 (USD Million)
13. Global Male Hypogonadism market by Topical gels, 2016-2026 (USD Million)
14. Global Male Hypogonadism market by Transdermal patches, 2016-2026 (USD Million)
15. Global Male Hypogonadism market by Others, 2016-2026 (USD Million)
16. Global Male Hypogonadism market revenue share, by Type, 2019 and 2026
17. Global Male Hypogonadism market by Kallmann syndrome, 2016-2026 (USD Million)
18. Global Male Hypogonadism market by Klinefelters syndrome, 2016-2026 (USD Million)
19. Global Male Hypogonadism market by Pituitary disorders, 2016-2026 (USD Million)
20. Global Male Hypogonadism market by Others, 2016-2026 (USD Million)
21. Global Male Hypogonadism market revenue share, by region, 2018 & 2025
22. North America Male Hypogonadism market, 2016-2026 (USD Million)
23. Europe Male Hypogonadism market, 2016-2026 (USD Million)
24. Asia Pacific Male Hypogonadism market, 2016-2026 (USD Million)
25. Latin America Male Hypogonadism market, 2016-2026 (USD Million)
26. Middle East & Africa Male Hypogonadism market, 2016-2026 (USD Million)
Table Of Tables
List of Tables
1. Global Male Hypogonadism market: snapshot
2. Drivers for Male Hypogonadism market: impact analysis
3. Restraints for Male Hypogonadism market: impact analysis
4. North America Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
5. North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
6. North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
7. North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
8. The U.S. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
9. The U.S. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
10. The U.S. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
11. Rest of North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
12. Rest of North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
13. Rest of North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
14. Europe Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
15. Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
16. Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
17. Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
18. U.K. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
19. U.K. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
20. U.K. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
21. France Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
22. France Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
23. France Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
24. Germany Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
25. Germany Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
26. Germany Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
27. Rest of Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
28. Rest of Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
29. Rest of Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
30. Asia Pacific Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
31. Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
32. Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
33. Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
34. China Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
35. China Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
36. China Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
37. Japan Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
38. Japan Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
39. Japan Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
40. India Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
41. India Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
42. India Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
43. Rest of Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
44. Rest of Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
45. Rest of Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
46. Latin America Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
47. Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
48. Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
49. Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
50. Brazil Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
51. Brazil Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
52. Brazil Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
53. Rest of Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
54. Rest of Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
55. Rest of Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
56. Middle East & Africa Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
57. Middle East & Africa Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
58. Middle East & Africa Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
Methodology
FrequentlyAsked Questions
Male hypogonadism is a medical condition, wherein the testes fail to generate enough testosterone which leads to incomplete development or delayed puberty.
The key factor that is driving the male hypogonadism market includes increasing cases of testosterone deficiency among men, increasing awareness among people about hypogonadism treatment owing to awareness drives that are organized by several governments across the world, and increasing infertility rates.
According to a study, the global male hypogonadism Industry size was $3.63 Billion in 2023 and is projected to reach $5.83 Billion by the end of 2032.
The global male hypogonadism market is expected to grow at a CAGR of 5.4% during the forecast period.
Some of the key market players that are involved in the male hypogonadism market include Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd., Finox Biotech, Teva Pharmaceutical Industries Ltd., Bayer AG, and IBSA Institut Biochimque
The global male hypogonadism market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed